23andMe has struck a $60 million deal with Genentech to analyze the genetic data of about 3,000 of its customers. The data will be used to develop a new treatment for Parkinson's disease.
23andMe to Sell DNA Data of Parkinson's Customers to Genentech for $60 Million
Tech Times - 8 Jan 2015 16:07
23andMe has struck a $60 million deal with Genentech to analyze the genetic data of about 3,000 of its customers. The data will be used to develop a new treatment for Parkinson's disease.
Share this Article
Recommended